• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
Medical Journal of Viral Hepatitis
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 9.1 (2025)
Volume Volume 8.2 (2024)
Volume Volume 8.1 (2024)
Volume Volume 7.3 (2023)
Volume Volume 7.2 (2023)
Volume Volume 7.1 (2022)
Volume Volume 6.3 (2022)
Volume Volume 6.2 (2022)
Issue Issue 2
Volume Volume 6.1 (2021)
Volume Volume 5.3 (2021)
Volume Volume 5.2 (2021)
Volume Volume 5.1 (2020)
Volume Volume 4.2 (2020)
Volume Volume 4.1 (2019)
Volume Volume 3.2 (2019)
Volume Volume 3.1 (2018)
Volume Volume 2.2 (2018)
Volume Volume 2.1 (2016)
Volume Volume 1.2 (2016)
Volume Volume 1.1 (2015)
Hassanin, F., Abbas, A., Schalaan, M., Rabea, M. (2022). Gaucher disease: Recent advances in the diagnosis and management.. Medical Journal of Viral Hepatitis, 6.2(2), 6-10. doi: 10.21608/mjvh.2022.234477
Fetouh Hassanin; Azza Hasan Abbas; Mona Schalaan; Mohamed Rabea. "Gaucher disease: Recent advances in the diagnosis and management.". Medical Journal of Viral Hepatitis, 6.2, 2, 2022, 6-10. doi: 10.21608/mjvh.2022.234477
Hassanin, F., Abbas, A., Schalaan, M., Rabea, M. (2022). 'Gaucher disease: Recent advances in the diagnosis and management.', Medical Journal of Viral Hepatitis, 6.2(2), pp. 6-10. doi: 10.21608/mjvh.2022.234477
Hassanin, F., Abbas, A., Schalaan, M., Rabea, M. Gaucher disease: Recent advances in the diagnosis and management.. Medical Journal of Viral Hepatitis, 2022; 6.2(2): 6-10. doi: 10.21608/mjvh.2022.234477

Gaucher disease: Recent advances in the diagnosis and management.

Article 3, Volume 6.2, Issue 2, April 2022, Page 6-10  XML PDF (176.18 K)
Document Type: Review articles
DOI: 10.21608/mjvh.2022.234477
View on SCiNiTO View on SCiNiTO
Authors
Fetouh Hassanin email orcid 1; Azza Hasan Abbas2; Mona Schalaan3; Mohamed Rabeaorcid 4
1Pediatrics, Misr International University, Cairo, Egypt
2Medical Parasitology, Immunology and Microbiology Department, National Hepatology and Tropical Medicine Research Institute (NHTMI), Cairo, Egypt
3Clinical Pharmacy department (Biochemistry), Misr International University, Cairo, Egypt.
4Department of Pediatric Gastroenterology, National Hepatology and Tropical Medicine Research Institute (NHTMI), Cairo, Egypt.
Abstract
Gaucher disease is a rare genetic disorder characterized by the deposition of glucocerebroside in cells of the macrophage-monocyte system. Gaucher disease is an inborn error of metabolism that affects the recycling of cellular glycolipids. This disease is a consequence of deficiency of the enzyme glucocerebrosidase. It causes bone pain, anemia, enlarged organs, painful belly and bruising and bleeding problems. There are many types of Gaucher disease, all cause similar symptoms in the organs and bones. Some forms of the disease also affect the brain. There is no cure for Gaucher disease, but a variety of treatments can help control symptoms, prevent irreversible damage and improve quality of life. Enzyme replacement therapy is the primary form of treatment for Gaucher disease.
Keywords
Gaucher disease; glucocerebrosidase; Enzyme replacement therapy and hepatosplenomegaly
Statistics
Article View: 760
PDF Download: 2,545
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.